Pipeline

Candidate vaccine

Frameshift target

Cancer (MSI) indication

Exploratory

Pre-clinical

Phase I

Phase II

FMPV-1

TGFbR2

Colorectal

Stomach

FMPV-2

ASTE1

Endometrial

FMPV-3

Multiple

MSI cancer